These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18925439)

  • 1. [Diagnosis of vascular parkinsonism: correlation of the symptoms with neuroimaging and utility of SPECT with 123I-ioflupane].
    Pérez Saldaña MT; Pérez Velasco R; Burguera JA
    Neurologia; 2008 Nov; 23(9):566-74. PubMed ID: 18925439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
    Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Negative predictive value of (123)I Ioflupane SPECT in movement disorders].
    Serrano Vicente J; García Bernardo L; Durán Barquero C; Constantino Silva A; Infante de la Torre JR; Domínguez Grande ML; Rayo Madrid JI; Sánchez Sánchez R; Durán Herrera C
    Rev Esp Med Nucl; 2009; 28(1):2-5. PubMed ID: 19232169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of
    Kotikova K; Zogala D; Ptacnik V; Trnka J; Kupka K; Vaneckova M; Seidl Z; Diblik P; Heissigerova J; Navratil T; Komarc M; Zak I; Polakova K; Brozova H; Zakharov S
    Clin Toxicol (Phila); 2021 Mar; 59(3):235-245. PubMed ID: 32762574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular parkinsonism--characteristics, pathogenesis and treatment.
    Korczyn AD
    Nat Rev Neurol; 2015 Jun; 11(6):319-26. PubMed ID: 25917706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.
    Prunier C; Payoux P; Guilloteau D; Chalon S; Giraudeau B; Majorel C; Tafani M; Bezard E; Esquerré JP; Baulieu JL
    J Nucl Med; 2003 May; 44(5):663-70. PubMed ID: 12732666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
    J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity.
    Wang HC; Hsu JL; Leemans A
    Arch Neurol; 2012 Oct; 69(10):1340-8. PubMed ID: 22825428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SPECT imaging using [123I]beta-CIT and [123I]IBF in extrapyramidal diseases].
    Sasaki T; Amano T; Hashimoto J; Itoh Y; Muramatsu K; Kubo A; Fukuuchi Y
    No To Shinkei; 2003 Jan; 55(1):57-64. PubMed ID: 12649900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of transcranial sonography in Parkinson's disease. A comparative study using 123I-FP-CIT SPECT].
    Hernández Vara J; Rubiera del Fueyo M; Lorenzo Bosquet C; Castell Conesa J; Molina Cateriano CA; Rodríguez FM
    Med Clin (Barc); 2008 Sep; 131(8):285-9. PubMed ID: 18803921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in Parkinsonism induced by pharmaceuticals].
    Duran-Ferreras E; Duran-Ferreras A
    Rev Neurol; 2011 Mar; 52(6):382-3. PubMed ID: 21387256
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders.
    Manoharan P; Jamieson S; Bury RF
    Clin Radiol; 2007 May; 62(5):463-71. PubMed ID: 17398272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular or "lower body Parkinsonism": rise and fall of a diagnosis].
    Szirmai I
    Ideggyogy Sz; 2011 Nov; 64(11-12):385-93. PubMed ID: 22611616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An MRI and SPECT study of frozen gait without other manifestations of parkinsonism in the elderly].
    Umahara T; Kano H; Iwamoto T; Katsunuma H; Tachikawa K; Tachikawa S
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):377-84. PubMed ID: 1895532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular parkinsonism--an important cause of parkinsonism in older people.
    Thanvi B; Lo N; Robinson T
    Age Ageing; 2005 Mar; 34(2):114-9. PubMed ID: 15713855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular parkinsonism: a distinct, heterogeneous clinical entity.
    Demirkiran M; Bozdemir H; Sarica Y
    Acta Neurol Scand; 2001 Aug; 104(2):63-7. PubMed ID: 11493219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.